Raymond James Trust N.A. Trims Holdings in Humana Inc. (NYSE:HUM)

Raymond James Trust N.A. lessened its holdings in Humana Inc. (NYSE:HUM) by 0.9% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 12,007 shares of the insurance provider’s stock after selling 115 shares during the period. Raymond James Trust N.A.’s holdings in Humana were worth $3,803,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently bought and sold shares of the business. Charles Schwab Investment Management Inc. boosted its holdings in shares of Humana by 3.0% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 899,191 shares of the insurance provider’s stock valued at $284,810,000 after acquiring an additional 26,056 shares during the last quarter. Massachusetts Financial Services Co. MA lifted its position in Humana by 42.0% during the third quarter. Massachusetts Financial Services Co. MA now owns 391,657 shares of the insurance provider’s stock valued at $124,053,000 after purchasing an additional 115,820 shares during the period. Landscape Capital Management L.L.C. boosted its holdings in Humana by 54.4% in the third quarter. Landscape Capital Management L.L.C. now owns 2,451 shares of the insurance provider’s stock valued at $776,000 after purchasing an additional 864 shares during the last quarter. Intech Investment Management LLC grew its position in Humana by 84.5% during the 3rd quarter. Intech Investment Management LLC now owns 114,209 shares of the insurance provider’s stock worth $36,175,000 after purchasing an additional 52,306 shares during the period. Finally, Cornerstone Advisors LLC raised its stake in shares of Humana by 5.0% during the 3rd quarter. Cornerstone Advisors LLC now owns 4,200 shares of the insurance provider’s stock valued at $1,330,000 after buying an additional 200 shares during the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research firms recently commented on HUM. JPMorgan Chase & Co. raised their target price on Humana from $332.00 to $396.00 and gave the stock a “neutral” rating in a report on Wednesday, August 21st. Leerink Partnrs cut shares of Humana from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. Jefferies Financial Group cut shares of Humana from a “buy” rating to a “hold” rating and cut their price objective for the company from $519.00 to $253.00 in a report on Monday, October 7th. Truist Financial lowered their target price on shares of Humana from $400.00 to $260.00 and set a “hold” rating on the stock in a research note on Friday, October 11th. Finally, Royal Bank of Canada cut their price target on Humana from $400.00 to $265.00 and set an “outperform” rating for the company in a research note on Tuesday, October 8th. Twenty investment analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $315.86.

Humana Price Performance

HUM stock opened at $298.11 on Friday. Humana Inc. has a 1 year low of $213.31 and a 1 year high of $527.18. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.76. The firm has a market capitalization of $35.90 billion, a PE ratio of 26.40, a price-to-earnings-growth ratio of 2.33 and a beta of 0.52. The business has a 50 day simple moving average of $276.83 and a 200-day simple moving average of $330.64.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.48 by $0.68. Humana had a return on equity of 13.20% and a net margin of 1.18%. The company had revenue of $29.30 billion during the quarter, compared to analysts’ expectations of $28.66 billion. Equities research analysts anticipate that Humana Inc. will post 15.86 earnings per share for the current fiscal year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be paid a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 1.19%. The ex-dividend date is Tuesday, December 31st. Humana’s dividend payout ratio (DPR) is presently 31.36%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.